CN1265035A - 抑制骨吸收的方法 - Google Patents
抑制骨吸收的方法 Download PDFInfo
- Publication number
- CN1265035A CN1265035A CN98807473A CN98807473A CN1265035A CN 1265035 A CN1265035 A CN 1265035A CN 98807473 A CN98807473 A CN 98807473A CN 98807473 A CN98807473 A CN 98807473A CN 1265035 A CN1265035 A CN 1265035A
- Authority
- CN
- China
- Prior art keywords
- bis
- phosphonic acids
- alendronic acid
- medication
- weekly
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/66—Phosphorus compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/66—Phosphorus compounds
- A61K31/662—Phosphorus acids or esters thereof having P—C bonds, e.g. foscarnet, trichlorfon
- A61K31/663—Compounds having two or more phosphorus acid groups or esters thereof, e.g. clodronic acid, pamidronic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/66—Phosphorus compounds
- A61K31/675—Phosphorus compounds having nitrogen as a ring hetero atom, e.g. pyridoxal phosphate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
- A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
- A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/08—Drugs for disorders of the urinary system of the prostate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/12—Drugs for disorders of the metabolism for electrolyte homeostasis
- A61P3/14—Drugs for disorders of the metabolism for electrolyte homeostasis for calcium homeostasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Physical Education & Sports Medicine (AREA)
- Epidemiology (AREA)
- Rheumatology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Urology & Nephrology (AREA)
- Diabetes (AREA)
- Endocrinology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Steroid Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Compounds Of Unknown Constitution (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Medicinal Preparation (AREA)
- Fittings On The Vehicle Exterior For Carrying Loads, And Devices For Holding Or Mounting Articles (AREA)
- Pit Excavations, Shoring, Fill Or Stabilisation Of Slopes (AREA)
- Aiming, Guidance, Guns With A Light Source, Armor, Camouflage, And Targets (AREA)
- Hydrogenated Pyridines (AREA)
- Saccharide Compounds (AREA)
Abstract
Description
食管刺激可能性研究 | ||||
组别 | 活 性 剂mg/ml | 用药方案 | 宰杀时间 | 病理组织学 |
1(n=4) | 0 | 每日1次共5日 | 紧接着最后一次用药之后 | 正常。完好的上皮,粘膜下层无炎性细胞。 |
2(n=4) | 阿仑膦酸类0.20 | 每日1次共5日 | 紧接着最后一次用药之后 | 上皮表面深度溃疡。显著粘膜下层发炎和空泡形成。 |
3(n=5) | 阿仑膦酸类0.80 | 1次 | 用药后24小时 | 完好的上皮表面,轻微的粘膜下层发炎和空泡形成。 |
4(n=5) | 阿仑膦酸类0.80 | 1次 | 用药后7日 | 完好的上皮,或者很少发炎(2/5的动物)或者没有发炎(3/5的动物)并且无空泡形成。 |
5(n=6) | 阿仑膦酸类0.80 | 每周1次共4次 | 用药后7日 | 完好的上皮,没有发炎,无空泡形成。 |
6(n=6) | 阿仑膦酸类0.40 | 每周2次共4周 | 紧接着最后一次用药之后 | 上皮表面深度溃疡。显著粘膜下层发炎和空泡形成。 |
7(n=8) | 瑞日膦酸类0.20 | 每日1次共5日 | 紧接着最后一次用药之后 | 上皮表面深度溃疡(4/8的动物)。显著粘膜下层发炎和空泡形成。 |
8(n=4) | 替鲁膦酸类4.0 | 每日1次共5日 | 最后一次用药24小时 | 轻微的粘膜下层发炎和空泡形成(3/4的动物,这些动物之一有轻微的溃疡) |
Claims (33)
Applications Claiming Priority (12)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US5335197P | 1997-07-22 | 1997-07-22 | |
US60/053,351 | 1997-07-22 | ||
US60/053351 | 1997-07-22 | ||
US5353597P | 1997-07-23 | 1997-07-23 | |
US60/053,535 | 1997-07-23 | ||
US60/053535 | 1997-07-23 | ||
GBGB9717590.5A GB9717590D0 (en) | 1997-08-20 | 1997-08-20 | Oral method for treating or preventing abnormal bone resorption |
US9717590.5 | 1997-08-20 | ||
GB9717590.5 | 1997-08-20 | ||
GB9717850.3 | 1997-08-22 | ||
GBGB9717850.3A GB9717850D0 (en) | 1997-08-22 | 1997-08-22 | Oral method for treating or preventing abnormal bone resorption |
US9717850.3 | 1997-08-22 |
Related Child Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CNA2004100557346A Division CN1602879A (zh) | 1997-07-22 | 1998-07-17 | 抑制骨吸收的方法 |
CNB2004100557350A Division CN1299689C (zh) | 1997-07-22 | 1998-07-17 | 阿仑膦酸在制备抑制骨吸收药物中的用途 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN1265035A true CN1265035A (zh) | 2000-08-30 |
CN1166365C CN1166365C (zh) | 2004-09-15 |
Family
ID=27451690
Family Applications (3)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CNA2004100557346A Pending CN1602879A (zh) | 1997-07-22 | 1998-07-17 | 抑制骨吸收的方法 |
CNB988074737A Ceased CN1166365C (zh) | 1997-07-22 | 1998-07-17 | 阿仑膦酸的药物组合物及其在制备抑制人的骨吸收的药物中的用途 |
CNB2004100557350A Expired - Lifetime CN1299689C (zh) | 1997-07-22 | 1998-07-17 | 阿仑膦酸在制备抑制骨吸收药物中的用途 |
Family Applications Before (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CNA2004100557346A Pending CN1602879A (zh) | 1997-07-22 | 1998-07-17 | 抑制骨吸收的方法 |
Family Applications After (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CNB2004100557350A Expired - Lifetime CN1299689C (zh) | 1997-07-22 | 1998-07-17 | 阿仑膦酸在制备抑制骨吸收药物中的用途 |
Country Status (31)
Country | Link |
---|---|
EP (5) | EP1151752A3 (zh) |
JP (2) | JP3479780B2 (zh) |
KR (3) | KR100391732B1 (zh) |
CN (3) | CN1602879A (zh) |
AT (2) | ATE357921T1 (zh) |
AU (1) | AU8493698A (zh) |
BG (1) | BG66282B1 (zh) |
BR (1) | BR9810779A (zh) |
CA (1) | CA2294595C (zh) |
CY (2) | CY1107535T1 (zh) |
DE (6) | DE122006000009I1 (zh) |
DK (2) | DK1175904T3 (zh) |
EA (1) | EA004544B2 (zh) |
EE (1) | EE05603B1 (zh) |
ES (3) | ES2269014T3 (zh) |
HK (5) | HK1024166A1 (zh) |
ID (1) | ID24096A (zh) |
IL (1) | IL133535A0 (zh) |
IS (3) | IS5315A (zh) |
LU (2) | LU91222I2 (zh) |
NL (2) | NL300223I1 (zh) |
NO (1) | NO20000323L (zh) |
NZ (1) | NZ501807A (zh) |
PL (1) | PL195272B1 (zh) |
PT (2) | PT1175904E (zh) |
SG (2) | SG139556A1 (zh) |
SI (1) | SI0998292T1 (zh) |
SK (1) | SK932000A3 (zh) |
TR (1) | TR200000145T2 (zh) |
UY (1) | UY25950A1 (zh) |
WO (1) | WO1999004773A2 (zh) |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN100345549C (zh) * | 2001-05-02 | 2007-10-31 | 诺瓦提斯公司 | 包含双膦酸的药用吸入组合物 |
CN106924257A (zh) * | 2017-03-14 | 2017-07-07 | 湖南赛隆药业有限公司 | 质子泵抑制剂和抗骨质疏松药的复合物及其用途 |
Families Citing this family (15)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP1147773B1 (en) | 1998-12-25 | 2004-04-07 | Yamanouchi Pharmaceutical Co. Ltd. | Medicinal compositions for treating osseous lesion in multiple myeloma |
KR100763064B1 (ko) * | 1999-05-21 | 2007-10-04 | 노파르티스 아게 | 제약 조성물 및 용도 |
EP1114642B1 (en) * | 1999-07-19 | 2010-01-06 | Toray Industries, Inc. | Drugs for periodontal diseases |
AU2580001A (en) | 1999-12-20 | 2001-07-03 | Merck & Co., Inc. | Blister package for pharmaceutical treatment card |
AU2270101A (en) * | 1999-12-20 | 2001-07-03 | Merck & Co., Inc. | Pharmaceutical kit |
US6943155B2 (en) * | 2000-04-07 | 2005-09-13 | Lenard M. Lichtenberger | Unique compositions of zwitterionic phospholipids and bisphosphonates and use of the compositions as bisphosphate delivery systems with reduced GI toxicity |
JP4722375B2 (ja) | 2000-06-20 | 2011-07-13 | ノバルティス アーゲー | ビホスホネートの投与法 |
US6638920B2 (en) * | 2000-07-21 | 2003-10-28 | Merck & Co., Inc. | Compositions and methods of preventing or reducing the risk or incidence of skeletal injuries in horses |
SE0101379D0 (sv) * | 2001-04-18 | 2001-04-18 | Diabact Ab | Komposition som hämmar utsöndring av magsyra |
BR0308901A (pt) * | 2002-05-10 | 2005-01-04 | Hoffmann La Roche | ácidos bisfosfÈnicos para tratamento e prevenção de osteoporose |
SE0203065D0 (sv) | 2002-10-16 | 2002-10-16 | Diabact Ab | Gastric acid secretion inhibiting composition |
KR20060058134A (ko) * | 2003-09-19 | 2006-05-29 | 화이자 프로덕츠 인코포레이티드 | 2-알킬리덴-19-노르-비타민 디 유도체 및비스포스포네이트의 조합을 포함하는 약학 조성물 및 방법 |
WO2005072747A1 (ja) * | 2004-02-02 | 2005-08-11 | Ono Pharmaceutical Co., Ltd. | 骨吸収抑制剤 |
EP1937362B1 (en) * | 2005-09-16 | 2013-03-27 | Selamine Ltd. | Bisphosphonate formulation |
CA2820019A1 (en) * | 2010-12-06 | 2012-06-14 | Effrx Pharmaceuticals Sa | Stable effervescent bisphosphonate formulations with rapid solubilization characteristics |
Family Cites Families (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
IL84731A0 (en) * | 1986-12-19 | 1988-05-31 | Norwich Eaton Pharma | Heterocycle-substituted diphosphonic acids and salts and esters and pharmaceutical compositions containing them |
SE8704436D0 (sv) * | 1987-11-13 | 1987-11-13 | Pm Konsult Handelsbolag | Anvendning av antisekretoriska substanser for nya indikationer |
ES2074769T3 (es) * | 1991-07-01 | 1995-09-16 | Gergely Gerhard | Procedimiento para la elaboracion de un preparado farmaceutico con, al menos, dos principios activos diferentes y uso de un preparado de este tipo. |
ATE195075T1 (de) * | 1991-11-22 | 2000-08-15 | Procter & Gamble Pharma | Risedronat enthaltende arzneimittel mit verzögerter wirkstoffabgabe |
US5270365A (en) * | 1991-12-17 | 1993-12-14 | Merck & Co., Inc. | Prevention and treatment of periodontal disease with alendronate |
US5294433A (en) * | 1992-04-15 | 1994-03-15 | The Procter & Gamble Company | Use of H-2 antagonists for treatment of gingivitis |
AU659329B2 (en) * | 1992-06-30 | 1995-05-11 | Procter & Gamble Pharmaceuticals, Inc. | Use of phosphonates for the treatment of osteoporosis |
US5431920A (en) * | 1993-09-21 | 1995-07-11 | Merck Frosst, Canada, Inc. | Enteric coated oral compositions containing bisphosphonic acid antihypercalcemic agents |
US5646134A (en) * | 1994-04-21 | 1997-07-08 | Merck & Co., Inc. | Alendronate therapy to prevent loosening of, or pain associated with, orthopedic implant devices |
WO1996039150A1 (en) * | 1995-06-06 | 1996-12-12 | Merck & Co., Inc. | Bisphosphonate therapy for bone loss associated with rheumatoid arthritis |
AU712710B2 (en) * | 1996-05-17 | 1999-11-11 | Merck Sharp & Dohme Corp. | Effervescent bisphosphonate formulation |
-
1998
- 1998-07-17 EP EP01201911A patent/EP1151752A3/en not_active Ceased
- 1998-07-17 CN CNA2004100557346A patent/CN1602879A/zh active Pending
- 1998-07-17 NZ NZ501807A patent/NZ501807A/en not_active IP Right Cessation
- 1998-07-17 CN CNB988074737A patent/CN1166365C/zh not_active Ceased
- 1998-07-17 DK DK01201913T patent/DK1175904T3/da active
- 1998-07-17 ES ES01201913T patent/ES2269014T3/es not_active Expired - Lifetime
- 1998-07-17 DE DE1998603291 patent/DE122006000009I1/de active Pending
- 1998-07-17 PL PL98338635A patent/PL195272B1/pl unknown
- 1998-07-17 ES ES98935752T patent/ES2164447T3/es not_active Expired - Lifetime
- 1998-07-17 KR KR1020007000680A patent/KR100391732B1/ko not_active IP Right Cessation
- 1998-07-17 JP JP50991499A patent/JP3479780B2/ja not_active Expired - Lifetime
- 1998-07-17 CN CNB2004100557350A patent/CN1299689C/zh not_active Expired - Lifetime
- 1998-07-17 DE DE200712000063 patent/DE122007000063I1/de active Pending
- 1998-07-17 CA CA002294595A patent/CA2294595C/en not_active Expired - Fee Related
- 1998-07-17 TR TR2000/00145T patent/TR200000145T2/xx unknown
- 1998-07-17 EP EP01201910A patent/EP1132088A3/en not_active Ceased
- 1998-07-17 SG SG200603406-0A patent/SG139556A1/en unknown
- 1998-07-17 EA EA200000151A patent/EA004544B2/ru not_active IP Right Cessation
- 1998-07-17 WO PCT/US1998/014796 patent/WO1999004773A2/en active Application Filing
- 1998-07-17 SG SG200107221A patent/SG109478A1/en unknown
- 1998-07-17 DE DE69803291T patent/DE69803291T2/de not_active Revoked
- 1998-07-17 DE DE01201911T patent/DE01201911T1/de active Pending
- 1998-07-17 AU AU84936/98A patent/AU8493698A/en not_active Abandoned
- 1998-07-17 ID IDW20000114A patent/ID24096A/id unknown
- 1998-07-17 IL IL13353598A patent/IL133535A0/xx unknown
- 1998-07-17 KR KR1020027013595A patent/KR20030097611A/ko not_active Application Discontinuation
- 1998-07-17 DE DE01201913T patent/DE01201913T1/de active Pending
- 1998-07-17 EP EP98935752A patent/EP0998292B1/en not_active Revoked
- 1998-07-17 DK DK98935752T patent/DK0998292T3/da active
- 1998-07-17 EE EEP200000040A patent/EE05603B1/xx unknown
- 1998-07-17 EP EP01201913A patent/EP1175904B8/en not_active Revoked
- 1998-07-17 DE DE69837450T patent/DE69837450T2/de not_active Expired - Lifetime
- 1998-07-17 EP EP01201912A patent/EP1175903A3/en not_active Ceased
- 1998-07-17 PT PT01201913T patent/PT1175904E/pt unknown
- 1998-07-17 AT AT01201913T patent/ATE357921T1/de active
- 1998-07-17 BR BR9810779-8A patent/BR9810779A/pt not_active Application Discontinuation
- 1998-07-17 AT AT98935752T patent/ATE209037T1/de active
- 1998-07-17 SK SK93-2000A patent/SK932000A3/sk not_active Application Discontinuation
- 1998-07-17 SI SI9830086T patent/SI0998292T1/xx unknown
- 1998-07-17 KR KR1020027013594A patent/KR20030097610A/ko not_active Application Discontinuation
- 1998-07-17 ES ES01201910T patent/ES2253136T1/es active Pending
- 1998-07-17 PT PT98935752T patent/PT998292E/pt unknown
-
1999
- 1999-12-21 IS IS5315A patent/IS5315A/is unknown
-
2000
- 2000-01-17 UY UY25950A patent/UY25950A1/es not_active Application Discontinuation
- 2000-01-18 BG BG104093A patent/BG66282B1/bg unknown
- 2000-01-21 NO NO20000323A patent/NO20000323L/no unknown
- 2000-05-12 HK HK00102840A patent/HK1024166A1/xx not_active IP Right Cessation
-
2002
- 2002-03-04 HK HK02101656.1A patent/HK1042230A1/zh unknown
- 2002-03-12 HK HK02101869.4A patent/HK1042232A1/zh unknown
- 2002-03-16 HK HK02102042.2A patent/HK1040494A1/zh unknown
- 2002-03-16 HK HK02102043.1A patent/HK1040495A1/zh unknown
-
2003
- 2003-03-10 JP JP2003063378A patent/JP2005068010A/ja active Pending
-
2004
- 2004-04-21 IS IS7230A patent/IS7230A/is unknown
- 2004-04-21 IS IS7231A patent/IS7231A/is unknown
-
2006
- 2006-02-07 NL NL300223C patent/NL300223I1/nl unknown
- 2006-02-15 LU LU91222C patent/LU91222I2/fr unknown
-
2007
- 2007-03-29 CY CY20071100442T patent/CY1107535T1/el unknown
- 2007-09-12 LU LU91364C patent/LU91364I2/fr unknown
- 2007-09-13 NL NL300292C patent/NL300292I1/nl unknown
- 2007-09-20 CY CY2007022C patent/CY2007022I2/el unknown
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN100345549C (zh) * | 2001-05-02 | 2007-10-31 | 诺瓦提斯公司 | 包含双膦酸的药用吸入组合物 |
CN106924257A (zh) * | 2017-03-14 | 2017-07-07 | 湖南赛隆药业有限公司 | 质子泵抑制剂和抗骨质疏松药的复合物及其用途 |
CN106924257B (zh) * | 2017-03-14 | 2019-11-19 | 湖南赛隆药业有限公司 | 质子泵抑制剂和抗骨质疏松药的复合物及其用途 |
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN1299689C (zh) | 阿仑膦酸在制备抑制骨吸收药物中的用途 | |
US6333316B1 (en) | Method for inhibiting bone resorption | |
CN1272013C (zh) | 二膦酸盐在制备用于治疗骨更新异常增加的病症的药物中的应用 | |
US6015801A (en) | Method for inhibiting bone resorption | |
CN1277545C (zh) | 二膦酸类化合物在制备用于治疗与前列腺癌有关的骨转移瘤的药物中的用途 | |
CN1142783C (zh) | 用于治疗高危葡萄糖耐量降低的药剂 | |
CN1535152A (zh) | 二膦酸类化合物在治疗疼痛方面的应用 | |
US6465443B2 (en) | Method for inhibiting bone resorption | |
JP2005516928A (ja) | 骨異常のためのビスホスホネート液体製剤 | |
CN1646137A (zh) | 治疗和预防甲状旁腺机能亢进的方法 | |
CN87105828A (zh) | 苏灵大或苏灵大钠和碱的速效组合物 | |
CN1681515A (zh) | 包含双膦酸类化合物和hmg-coa还原酶抑制剂的组合疗法 | |
CN1681516A (zh) | 预防或减少髋部骨折后继发性骨折的方法 | |
CN1411386A (zh) | 低骨矿质密度的治疗 | |
CN1711090A (zh) | 用于治疗慢性淋巴细胞白血病的氮芥类似物和甲磺酸依马替尼的组合 | |
EP2162129B1 (en) | Use of hdac inhibitors for the treatment of bone destruction | |
CN1919200A (zh) | 抑制骨吸收的方法 | |
WO2000038694A1 (fr) | Compositions de medicaments servant a traiter les lesions osseuses dans le myelome multiple | |
SK159597A3 (en) | Use of alendronate for the prevention of osteoporosis | |
CN1921866A (zh) | 使用雷洛昔芬和阿伦膦酸盐的改善的联合治疗 | |
CN1191833C (zh) | 牙周病治疗药 | |
JP5707137B2 (ja) | レバミピドの骨粗鬆症治療用途 | |
MXPA00000789A (en) | Method for inhibiting bone resorption | |
UA67748C2 (uk) | Активний інгредієнт для виробництва лікарського засобу для інгібування резорбції кісткової тканини у людини (варіанти) | |
HRP20000035A2 (en) | Method for inhibiting bone resorption |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
C56 | Change in the name or address of the patentee |
Owner name: MERCK & CO. INC. Free format text: FORMER NAME OR ADDRESS: MERCK + CO., INC. |
|
CP03 | Change of name, title or address |
Address after: New Jersey, USA Patentee after: Merk & Co. Inc. Address before: New Jersey, USA Patentee before: MERCK & Co.,Inc. |
|
C35 | Partial or whole invalidation of patent or utility model | ||
IW01 | Full invalidation of patent right |
Decision date of declaring invalidation: 20071102 Decision number of declaring invalidation: 10569 |
|
C56 | Change in the name or address of the patentee | ||
CP01 | Change in the name or title of a patent holder |
Address after: New Jersey, USA Patentee after: Schering Corporation Address before: New Jersey, USA Patentee before: Merk & Co. Inc. |
|
C35 | Partial or whole invalidation of patent or utility model | ||
IW01 | Full invalidation of patent right |
Decision date of declaring invalidation: 20071102 Decision number of declaring invalidation: 10569 Granted publication date: 20040915 |